Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to ...

With a new production line up and running at its latest facility in the greater Boston area, family-owned German CDMO ...

Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce ...

Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a ...

Even as pharma companies have yet to feel the full effects of the Inflation Reduction Act, Senate lawmakers have turned their ...

Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the ...

After a break for the Fourth of July holiday in the U.S., we're back with two weeks' worth of biopharma news from Asia.